Unknown

Dataset Information

0

Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16(INK4a) expression in subjects on combination therapy.


ABSTRACT: HIV may amplify immunological, physiological and functional changes of ageing. We determined associations of frailty phenotype, a T-cell senescence marker (p16(INK4a) expression), age and demographics with exposures of the intracellular metabolites (IM) and endogenous nucleotides (EN) of tenofovir/emtricitabine (TFV/FTC), efavirenz (EFV), atazanavir (ATV) and ritonavir (RTV).Plasma and peripheral blood mononuclear cell samples for drug, IM and EN concentrations were collected at four time points in HIV+ adults receiving TFV/FTC with EFV or ATV/RTV. Subjects underwent frailty phenotyping and p16(INK4a) expression analysis. Non-compartmental analysis generated an area under the curve (AUC) for each analyte. Spearman rank correlation and Kruskal-Wallis tests were used to assess associations between AUC, demographics and ageing markers, adjusting for multiple comparisons with the Holm procedure.Subjects (n=79) ranged in age from 22-73 years (median 48 years); 48 were African-American, 24 were female, 54 received EFV. Three subjects (range 51-60 years) demonstrated frailty, with 17 subjects (range 26-60 years) demonstrating pre-frailty. Negative associations were observed between p16(INK4a) expression and each of FTC-triphosphate (r=-0.45), deoxyadenosine triphosphate (dATP; r=-0.47) and deoxycytidine triphosphate (dCTP; r=-0.57) AUCs (P-values <0.02). TFV and FTC AUCs were larger among subjects with lower renal function or higher chronological age (P-values ?0.05). No associations were observed for EFV, ATV or RTV AUCs.Associations of IM/EN exposure and p16(INK4a) expression observed here suggest that senescence may alter drug phosphorylation, metabolism or transport. This finding warrants further mechanistic study to ensure optimal treatment in the ageing HIV+ population. Clinicaltrials.gov NCT01180075.

SUBMITTER: Dumond JB 

PROVIDER: S-EPMC5266614 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16(INK4a) expression in subjects on combination therapy.

Dumond Julie B JB   Francis Owen O   Cottrell Mackenzie M   Trezza Christine C   Prince Heather Ma HM   Mollan Katie K   Sykes Craig C   Torrice Chad C   White Nicole N   Malone Stephanie S   Wang Ruili R   Van Dam Cornelius C   Patterson Kristine B KB   Hudgens Michael G MG   Sharpless Norman E NE   Forrest Alan A  

Antiviral therapy 20160105 5


<h4>Background</h4>HIV may amplify immunological, physiological and functional changes of ageing. We determined associations of frailty phenotype, a T-cell senescence marker (p16(INK4a) expression), age and demographics with exposures of the intracellular metabolites (IM) and endogenous nucleotides (EN) of tenofovir/emtricitabine (TFV/FTC), efavirenz (EFV), atazanavir (ATV) and ritonavir (RTV).<h4>Methods</h4>Plasma and peripheral blood mononuclear cell samples for drug, IM and EN concentrations  ...[more]

Similar Datasets

| S-EPMC5201235 | biostudies-literature
| S-EPMC9296590 | biostudies-literature
| S-EPMC5321809 | biostudies-literature
| S-EPMC4898685 | biostudies-other
| S-EPMC9267940 | biostudies-literature
| S-EPMC3007178 | biostudies-literature
| S-EPMC2274865 | biostudies-literature
| S-EPMC5438955 | biostudies-literature
| S-EPMC7449168 | biostudies-literature
| S-EPMC4576083 | biostudies-literature